Variant report
Variant | esv3391589 |
---|---|
Chromosome Location | chr5:58025195-58026393 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:58022097..58023766-chr5:58024865..58027239,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181522421 | chr5:58025251-58025252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139372269 | chr5:58025284-58025285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549238954 | chr5:58025285-58025286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567733728 | chr5:58025292-58025293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35569057 | chr5:58025305-58025306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537867255 | chr5:58025315-58025316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373196127 | chr5:58025359-58025360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150005253 | chr5:58025390-58025391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571566878 | chr5:58025445-58025446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72760302 | chr5:58025448-58025449 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs187052577 | chr5:58025468-58025469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565926767 | chr5:58025486-58025487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191700143 | chr5:58025507-58025508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145254926 | chr5:58025508-58025509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12659579 | chr5:58025513-58025514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576062234 | chr5:58025527-58025528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71626119 | chr5:58025562-58025563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200099497 | chr5:58025578-58025579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533318632 | chr5:58025610-58025611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6895043 | chr5:58025624-58025625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543055532 | chr5:58025678-58025679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13359889 | chr5:58025683-58025684 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs576422592 | chr5:58025712-58025713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185627389 | chr5:58025721-58025722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560392179 | chr5:58025722-58025723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566791089 | chr5:58025741-58025742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540894051 | chr5:58025757-58025758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142326848 | chr5:58025769-58025770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11357252 | chr5:58025793-58025794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189695585 | chr5:58025797-58025798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532354805 | chr5:58025820-58025821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531783710 | chr5:58025828-58025829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182207140 | chr5:58025883-58025884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571707332 | chr5:58025909-58025910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372812853 | chr5:58025932-58025933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144619696 | chr5:58025962-58025963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547739666 | chr5:58025973-58025974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34833784 | chr5:58026046-58026047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565962023 | chr5:58026080-58026081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113234996 | chr5:58026096-58026097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs147629938 | chr5:58026194-58026195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569663021 | chr5:58026197-58026198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs293008 | chr5:58026255-58026256 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs558228158 | chr5:58026341-58026342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:58022800-58029000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr5:58025000-58026600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:58026200-58026400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |